NEBULIZER THERAPY FOR ACUTE BRONCHIAL OBSTRUCTION IN CHILDREN.

Abstract

  Bronchial obstruction syndrome in children is a widespread pathological condition.
Allergic inflammation of the mucous membrane of the respiratory tract with the participation
of leukotrienes leads to the development of this syndrome in bronchial obstruction. It was
found that blocking leukotriene receptors with the help of the drug decosan has a therapeutic
effect, including in infants. The drugs are well tolerated, are able to prevent bronchospasm,
and in some clinical situations can be used as an alternative to glucocorticoids.